Delighted to be back in person at #ISPOREurope - with AESARA & AESARA Client #ValueEvidence research on show. Come find us in Vienna!
3
Delighted to be back in person at #ISPOREurope - with AESARA & AESARA Client #ValueEvidence research on show. Come find us in Vienna!
1
3
Looking forward to being back in person at #ISPORAnnual . SO much AESARA research and insight on show too.
#ValueEvidence
aesara.com/ispor-2022/
1
1
For the clinical stage #biotech Europe can seem too difficult to bother with BUT - whether you are going alone or seeking a partner - creating an evidence-based European access strategy is possible (especially before you lock in Phase 3!)
aesara.com/2022/04/who-do-i-โฆ
#ValueEvidence
2
3
23 Feb 2022
This ๐. Never a truer word spokenโฆ(succinctly, quietly, humbly without dominating ๐ค) #valuethequietvoices #valuereflectors #valueexpertise #valueevidence
23 Feb 2022
The person who talks the most is the most likely to become the leader.
Data: regardless of intelligence and expertise, groups elevate those who command the most airtime.
It's time to stop rewarding people for dominating the discussion, and start valuing quality over quantity.
1
9
Access to #GeneTherapies in Europe reliant on post-approval #RWE & EU-level co-ordinated data requirements, agree #ISPOREurope panellists @eurordis @Novartis & ex- @NICEComms - but can a small, innovator #Biotech afford to meet the ask while waiting for full P&R?
#ValueEvidence
2
2
โIf Someone Doesn't #ValueEvidence, What #Evidence Are You Going To Provide To #Prove That They Should #Value It?โ
~Sam Harris
@JoeBiden @POTUS @GovEvers @WisDOJ @digitalspy @WISCTV_News3 @Newsweek @WISN12News @PostCrescent @chicagotribune
#ReleaseTheRav to @ZellnerLaw
1
6
13
Patient, HTA & developer perspectives on next wave #celltherapies (eg CAR-NK) at #DIAEurope2021
1. Narrow access to CAR-Ts has to be improved upon
2. #ValueEvidence asks vary across EU countries & alignment would help
3. Patients are involved but with what impact on decisions?
Allogeneic #CellTherapies create new opportunities for #Cancer care, with faster treatment and lower costs than autologous therapies.
Join AESARA at #DIAEurope to hear an expert panel explore how to enable these advances from patient, HTA and industry perspectives.
1
4
Super #DIAEurope2021 panel. Takeaways:
1. Consensus to improve impact of patient input to HTA
2. Solutions include an explicit section in HTA reports for patient input, with new methods for assessing it
3. Industry has a key role in turning patient experience into #ValueEvidence
How do European #HTA processes hear the patient voice?
Could they do better?
Join AESARA at #DIAEurope to hear from industry, HTA and patient perspectives how it works now and where it might improve.
#PatientCentricity
1
2
25 Nov 2020
With lots of convo at the moment on the value of Mentoring in our sector & need for evaluation data on their outcomes/ potential impact - it makes us grateful to have skills within our team & partners to evaluate our initiatives, otherwise would be tough to do #valueevidence
25 Nov 2020
Proud as punch listening to @amyjvassallo present her (very!) early evaluation data for the 2018 @FranklinWomen Mentoring Program cohort in partnership with her @georgeinstitute colleagues @KClyde14 @rohinajoshi ๐๐ canโt wait to share with participants once analysed #Evidence
4
10
"good evidence must have a role in defining price" - hard to disagree with Steven Pearson (Founder and President, @icer_review ) on this!
#ValueEvidence
#FTPharma
1
2
Chantal Guilhaume of @HAS_sante & @EUnetHTA advocates for multi-national scientific advice to create alignment in ev gen needs, increasing likelihood of desired data being generated.
Cites CAR-Ts as case where Europe HTABs had similar PLEG demands.
#DIAEurope2020
#ValueEvidence
2
Payers tell us they get frustrated with rigid, inflexible product value presentations.
#Payers prefer to skip to the information they need - and have a dynamic dialogue with MSLs & HOLs.
Tell us what frustrates you the most in product presentations?
#HCEI #ValueEvidence
1
3
12 Nov 2019
And we're off! #WODC2019 is officially underway.
"Balancing on the Edge - #ValueEvidence and #MarketAccess for #OrphanDrygs in the US & EU" from #MME
1
1
6
28 Mar 2018
Good news ! Thank you @g7 for listening and thank you @Y7Canada and @YDCanada for representing the youth ๐ looking forward to have young scientists at the table too ! #Scipol #evidencebasedpolicymaking #valueevidence #scidip
27 Mar 2018
It was an honour to speak today at the first @g7 Ministerial and discuss how youth will engage in the new economy and what the #futureofwork looks like. Thank you Min. @PattyHajdu for inviting @Y7Canada and @YDCanada to the table to participate! #myG7 #Y72018
1
4